Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Patient leaflets

This article was originally published in The Tan Sheet

Executive Summary

Leaflets on drugs currently provided to patients do not provide information they value and find useful, according to researchers. In Health Technology Assessment, D.K. Raynor, Pharmacy Practice and Medicines Management Group, University of Leeds School of Healthcare, U.K., et al., say most people do not value written information they receive about drugs. Patients want to know about possible adverse events and require information to help decide whether to take a medicine. "The readability of medicines' information is important to patients, with concerns about complex language and poor visual presentation," Raynor et al. say. They included 64 papers after conducting a database search and tabulating results...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100386

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel